Healthcare Services India

India Diabetes Prevention Programs Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

India Diabetes Prevention Programs Market Industry Trends and Forecast to 2034: Segmented by (Delivery, Payer, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

India · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $67.0 Mn Placeholder estimate
Estimate 2025 $76.1 Mn 2% of the global market
Projected 2034 $239.9 Mn 215.1% Adds $163.8 Mn over 9 forecast years
CAGR 2025–2034 13.6% Faster than 64% of 107 Healthcare Services markets here
Key players 5
  • India is 1.99% of the global market.
  • In APAC, the largest is China at $353.8 Mn.
  • Fastest growing: India (this report) at 13.6% a year.
  • India ranks 3rd of 10 by size in APAC.

Market size projection

India

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$163.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Diabetes Prevention Programs Market market size by year, India
YearMarket sizeChange that yearSince 2025
2024 (estimate) $67.0 Mn — —
2025 (base) $76.1 Mn +$9.1 Mn —
2026 (forecast) $86.5 Mn +$10.4 Mn +13.6%
2027 (forecast) $98.3 Mn +$11.8 Mn +29%
2028 (forecast) $111.6 Mn +$13.4 Mn +46.6%
2029 (forecast) $126.8 Mn +$15.2 Mn +66.5%
2030 (forecast) $144.0 Mn +$17.2 Mn +89.2%
2031 (forecast) $163.6 Mn +$19.6 Mn +114.9%
2032 (forecast) $185.9 Mn +$22.3 Mn +144.1%
2033 (forecast) $211.2 Mn +$25.3 Mn +177.3%
2034 (forecast) $239.9 Mn +$28.7 Mn +215.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $3.82 Bn
  2. North America $1.79 Bn
  3. US $1.59 Bn
  4. APAC $807.2 Mn
  5. Europe $744.2 Mn
  6. China $353.8 Mn
  7. Canada $286.6 Mn
  8. Japan $244.6 Mn
  9. Latin America $197.6 Mn
  10. Middle East $161.7 Mn
  11. Germany $133.2 Mn
  12. France $107.0 Mn
  13. Brazil $90.8 Mn
  14. UK $84.2 Mn
  15. Italy $83.2 Mn
  16. Ecuador $76.4 Mn
  17. India (this report) $76.1 Mn
  18. Spain $67.9 Mn
  19. Mexico $62.1 Mn
  20. Saudi Arabia $62.2 Mn
  21. Africa $60.3 Mn
  22. Australia $46.5 Mn
  23. New Zealand $40.2 Mn
  24. Russia $38.6 Mn
  25. South Africa $22.1 Mn
  26. UAE $17.8 Mn
  27. Egypt $10.3 Mn
  28. Philippines $9.4 Mn
  29. Malaysia $6.9 Mn
  30. Hong Kong $6.5 Mn
  31. Thailand $5.2 Mn
  32. Singapore $4.2 Mn
  33. Kenya $2.4 Mn

Report snapshot

India Diabetes Prevention Programs Market Analysis at a glance
Market size, 2025$76.1 Mn placeholder estimate
Forecast, 2034$239.9 Mn placeholder estimate
Growth (CAGR), 2025–203413.6% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsDelivery, payer and end user (see all)
Key playersOmada Health, Virta Health, Lark Health, WW International, Livongo Health (now part of Teladoc Health) (see all)
Active clinical trials2 in IndiaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in India. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The India Diabetes Prevention Programs Market Analysis Executive Summary

Diabetes prevention programs help people with prediabetes lower their risk of type 2 diabetes through coaching on diet, activity and weight.

Key segments of the diabetes Prevention Programs market include delivery (In-Person Programs, Digital Programs and Hybrid Programs) and payer (Employers, Health Plans and Government).

Bar chart: India Diabetes Prevention Programs market size, 2024–2034, placeholder estimates. $67.0 Mn in 2024, $76.1 Mn in 2025 and $239.9 Mn in 2034, 13.6% CAGR.
India Diabetes Prevention Programs market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

India Diabetes Prevention Programs Market Dynamics

Market Growth Drivers

Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the diabetes Prevention Programs market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.

Opportunity

Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the diabetes Prevention Programs market, especially in fast-growing emerging economies.

Market Restraints

High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the diabetes Prevention Programs market. Long-term safety data and lifestyle support are still needed for many patients.

Competitive Landscape for Diabetes Prevention Programs Market in India

The diabetes Prevention Programs market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Diabetes Prevention Programs Market in India

Diabetes Prevention Programs in India: payment and research

Ayushman Bharat PM-JAY gives eligible families hospital cover of up to ₹5 lakh a year.⁠[1] ClinicalTrials.gov lists 2 studies on Diabetes Prevention Programs that are recruiting, active or about to start in India.⁠[2] Diabetes (adults): 22.6% of adults in 2022, the latest WHO figure for India.⁠[3]

[1] National Health Authority (PM-JAY). Checked 14 Nov 2026.

[2] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in India. Retrieved 12 Nov 2026.

[3] WHO Global Health Observatory, Diabetes (adults, WHO) (% of adults). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Licensing, quality standards and payment models from public and private payers shape how diabetes Prevention Programs services are delivered and paid for in India. Government health programs and insurance coverage are key to access.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Diabetes Prevention Programs right now, from free public sources.

Latest research 134 papers since 2021 (worldwide)

  1. Understanding How to Make Type 2 Diabetes Prevention Programs More Inclusive: An Equity-Oriented Qualitative Case Study of Small Steps for Big Changes. Healthcare (Basel, Switzerland), 2026
  2. Plan for Scale Out: Adapting a Diabetes Prevention Program for Implementation in Rural and Remote British Columbia. International journal of behavioral medicine, 2026
  3. Comment on Qiang et al. The Effectiveness of Diabetes Prevention Programs Delivered in Primary Care for Individuals With Prediabetes or at Risk of Developing Type 2 Diabetes: A Systematic Review and Meta-analysis. Diabetes care, 2026
  4. A Tailored Approach to Increase Engagement in Lifestyle Change Programs in Women With Previous Gestational Diabetes Mellitus. Diabetes, obesity, and cardiometabolic CARE, 2026
  5. AI-Driven Lifestyle Interventions for Reducing Diabetes Risk: Systematic Review. Journal of medical Internet research, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Diabetes Prevention Programs in context

India compared

  • Diabetes (adults, WHO): 22.6% of adults (2022). World: 14.1% of adults (2022). 4th highest of the 15 countries we cover in APAC.[1]
  • Health spending per person: 85 US$ per person (2023). World: 1,317 US$ per person (2023). 10th highest of the 15 countries we cover in APAC.[2]
  • Doctors: 0.72 per 1,000 people (2020). World: 1.86 per 1,000 people (2022). 11th highest of the 15 countries we cover in APAC.[3]

[1] WHO Global Health Observatory, Diabetes (adults, WHO) (% of adults). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Diabetes Prevention Programs market in India?
Placeholder estimate: about $76.1 Mn in 2025, rising to about $239.9 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Diabetes Prevention Programs market in India growing?
Placeholder estimate: about 13.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Diabetes Prevention Programs market report cover?
The report splits the market by delivery (In-Person Programs, Digital Programs, Hybrid Programs), payer (Employers, Health Plans, Government) and end user (Hospitals, Clinics, Home Care, Corporate and Payer Clients).
Who are the key players in the Diabetes Prevention Programs market?
Key players include Omada Health, Virta Health, Lark Health, WW International and Livongo Health (now part of Teladoc Health).
What is driving the Diabetes Prevention Programs market?
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the diabetes Prevention Programs market.
How is healthcare paid for in India?
Ayushman Bharat PM-JAY gives eligible families hospital cover of up to ₹5 lakh a year. Source: National Health Authority (PM-JAY). Checked 14 Nov 2026.
How many clinical trials on Diabetes Prevention Programs are running in India?
2 studies are recruiting, active or about to start in India, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in India. Retrieved 12 Nov 2026.
What does WHO report for India?
Diabetes (adults): 22.6% of adults in 2022, the latest WHO figure. Source: WHO Global Health Observatory, Diabetes (adults, WHO) (% of adults). Retrieved 15 Nov 2026.
How many people in India are 65 or older?
7.4% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 15 Nov 2026.
How much research is published on Diabetes Prevention Programs?
PubMed lists 134 papers on Diabetes Prevention Programs added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Diabetes Prevention Programs in India? Our analysts can size it for your plan. Talk to us See the public data Diabetes (adults, WHO) for every country, free. Open the Public Health Dashboard

From our blog

Weight Management Supplements in the GLP-1 Era2.6 billion adults are overweight. GLP-1 medicines are changing weight care, while most supplements lack… Wound Care: Advanced Dressings for Faster HealingNearly 15% of US Medicare beneficiaries, 8.2 million people, had a wound or wound infection in one year… Snoring and Sleep Apnoea Devices: Sleeping BetterAn estimated 936 million adults have obstructive sleep apnoea, and most are undiagnosed. CPAP machines, oral…
Back to Catalogue
Keep exploring

Related Healthcare Services reports in India

See all
Same topic, other categories

Related on obesity and diabetes

See the topic